Immunoprecise Antibodies Financials
| IPA Stock | USD 0.35 0.02 6.06% |
Immunoprecise |
Understanding current and past Immunoprecise Antibodies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Immunoprecise Antibodies' financial statements are interrelated, with each one affecting the others. For example, an increase in Immunoprecise Antibodies' assets may result in an increase in income on the income statement.
Please note, the presentation of Immunoprecise Antibodies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Immunoprecise Antibodies' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Immunoprecise Antibodies' management manipulating its earnings.
Immunoprecise Antibodies Stock Summary
Immunoprecise Antibodies competes with Recursion Pharmaceuticals, Atea Pharmaceuticals, Unity Biotechnology, Shattuck Labs, and Champions Oncology. ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada. Immunoprecise Antibodies is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | CA45257F2008 |
| CUSIP | 45257F200 45257F101 |
| Location | British Columbia; Canada |
| Business Address | 32044464 Markham Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ipatherapeutics.com |
| Phone | 250 483 0308 |
| Currency | USD - US Dollar |
Immunoprecise Antibodies Key Financial Ratios
Immunoprecise Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immunoprecise Antibodies's current stock value. Our valuation model uses many indicators to compare Immunoprecise Antibodies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immunoprecise Antibodies competition to find correlations between indicators driving Immunoprecise Antibodies's intrinsic value. More Info.Immunoprecise Antibodies is rated below average in return on equity category among its peers. It is rated second overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immunoprecise Antibodies' earnings, one of the primary drivers of an investment's value.Immunoprecise Antibodies Systematic Risk
Immunoprecise Antibodies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Immunoprecise Antibodies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Immunoprecise Antibodies correlated with the market. If Beta is less than 0 Immunoprecise Antibodies generally moves in the opposite direction as compared to the market. If Immunoprecise Antibodies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Immunoprecise Antibodies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Immunoprecise Antibodies is generally in the same direction as the market. If Beta > 1 Immunoprecise Antibodies moves generally in the same direction as, but more than the movement of the benchmark.
About Immunoprecise Antibodies Financials
What exactly are Immunoprecise Antibodies Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Immunoprecise Antibodies' income statement, its balance sheet, and the statement of cash flows. Potential Immunoprecise Antibodies investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Immunoprecise Antibodies investors may use each financial statement separately, they are all related. The changes in Immunoprecise Antibodies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immunoprecise Antibodies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Immunoprecise Antibodies March 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Immunoprecise Antibodies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immunoprecise Antibodies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immunoprecise Antibodies based on widely used predictive technical indicators. In general, we focus on analyzing Immunoprecise Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immunoprecise Antibodies's daily price indicators and compare them against related drivers.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 42.15 | |||
| Value At Risk | (9.24) | |||
| Potential Upside | 10.53 |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world |